chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 050C21A and 016C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.            No concomitant medications were reported by the reporter. No treatment medications were reported by the reporter. Action taken with mRNA-1273 Moderna COVID-19 Vaccine was not applicable   This case was linked to MOD-2021-255876 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow up received and does not contain any new information.
It was reported that a 17 year old female pt received Menomune and aplisol on 6/23/03. Two days later, the pt experienced a half dollar size swelling with redness, itching and a hive at the injection site. The pt was treated with Benadryl 25milligrams given orally. She fully recovered within 24 hrs.
Individual received FLU vaccination on 11/12/2021. Immediately following Vaccine, individual felt a sharp pain after receiving injection. Right Shoulder became very painful throughout the day.  States she had difficulty lifting shoulder due to pain. States she had difficulty lifting her right arm/shoulder to reach steering wheel. Denies numbness or tingling of extremity. Site was warm to touch at injection site but denied redness or swelling. Pain radiates down right arm with certain movement. Indicated that pain was worse the first day or two with slight improvement the days following but did not go away completely. Individual stated that although there was some improvement, the pain has worsened, and movement has become more painful as time as gone on.
pt recv vax 24NOV97 & sometime later on the same day pt exp a rash (red bumps) & itching of the arms & legs;
swelling of knuckles on hands, elbows, knees w/macular, reddened rash on both sides of hands & on elbows & knees; c/o h/a, blurred vision & soreness in eyes;
Achiness; sinus pressure; headache; diarrhea; chills; fever.
1 to 8 hour after injection was fatigue  8 hours after the injection there was fatigue,  fever, chills, body aches, headache  4 days after to present- occasional feelings of anxiety that did not pre-exist
Myalgia, Fever, Diarrhea, fatigue Narrative:  Patient called to report after 2nd dose on Tues/Wednesday she c/o fatigue, body aches, diarrhea and fever, stayed home from work.
First became very tired. Then shivering, sweating, fever (101 degrees), injection site pain and a very upset stomach (dry heaves). I couldn't sleep, haven't felt that bad in a long time. My stomach is still bothering me days later.
Tiredness; Headache; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of FATIGUE (Tiredness) and HEADACHE (Headache) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    No Medical History information was reported.   On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On 19-Mar-2021, the patient experienced HEADACHE (Headache). On 18-May-2021, the patient experienced FATIGUE (Tiredness). At the time of the report, FATIGUE (Tiredness) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
A report was received from a health care professional on 12Nov03, concerning an unspecified number of vaccinees under 4 years who have inadvertently received Fluvirin on unspecified date. On an unspecified date vaccinees under 4 years inadvertently received Fluvirin IM. The vaccinee did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporters causality assessment. Update 1, 07Jan04. A follow up report was received from a health care professional concerning a 2 year old male vaccine who inadvertently received Fluvirin on 07Nov03. On 07Nov03, the vaccinee inadvertently received Fluvirin. The vaccinee did not experienced any adverse symptoms at the time of reporting. No follow up pending, all information received. Multiple report cross reference with: PJP200301062, PJP200400063, PJP200400064, PJP200400065, PJP200400066, PJP200400067, PJP200400068, PJP200400069, PJP200400070, PJP200400072, PJP200400073, PJP200400074, PJP200400075, PJP200400076, PJP200400077, PJP200400078, PJP200400079.
Local reaction at injection site including soreness, warmth, erythema, swelling, induration, and fever 101.5. Tylenol/Medrol dose pack, Vicodin ES.
Severe migraine like headache, light sensitivity, eye pain and strain, hallucinations, mild fever, tremors, confusion, fatique, muscle weakness, exhaustion, trouble speaking.  Began on 9/24 in the morning and progressed throughout the night.  The next 4 days continued with headache, eye pain, and exhaustion.  Symptoms still continue mildly.  I believe it is encephalitis.
Patient suffers from dizziness and becomes flaccid. We proceeded to look for the equipment while her mother and grandmother held her in the chair. A mattress was prepared and the patient was laid down and evaluated s/v. She reflects hypotension and bradycardia, the patient was conscious at the time. She never lost consciousness and was monitored with pulse oximetry and reassessed B/P. Patient shows signs of recovery, pulse begins to rise to normal parameters, he proceeds to sit down and then stands up and sits on the chair where he is kept under observation for 30 min. Patient shows able to stand and his mother takes over. The mother was advised about the possible episode that occurred to her, vasovagal. It is recommended that you mention it in future vaccinations and inform the patients' physician.
pt recvd vax 15NOV95 & began w/eruption of lesions 26NOV & 27NOV95;total of 50 chicken pox type lesions per description on face/belly/back/arms/legs;usual rxn <15;eyes appear glassy per mom + itch;family has relative on Pred & 1 w/AIDS
Information has been received from a physician concerning a 25 weeks old patient who on 08-AUG-2011, at 12 weeks 6 days of age, was vaccinated with the first dose of ROTATEQ (Lot# not reported) and on 03-NOV-2011, vaccinated the second dose of ROTATEQ (Lot# not reported). The third dose had not been administered yet. No adverse event reported. The patient sought medical attention by an office visit. Additional information has been requested. This is an amended report, the reporting status change to periodic.
This is a spontaneous report from a contactable consumer via Pfizer sales representative. An adult patient of an unspecified ethnicity and gender received a single dose of PREVNAR 13, on an unspecified date Mar2016. The patient medical history and concomitant medications were not reported. On an unspecified date in Mar2016 the patient experienced very red, swollen area on arm so went to an immediate care clinic. Patient was diagnosed with cellulitis and prescribed antibiotics. The outcome of the event was unknown.
3/31/11 pt had a rash & mother stated felt warm. Assessed diffuse rash with streaks of papular erythema. Given BENADRYL 12.5 mg/5mL 1-2 tsp Q 6 hrs PRN. 4/4/11 pt returned to clinic rash is raised, turned yellow, filling with fluid. Dr. dx'd Varicella.
pt called 27JAN97 to report following 45min p/vax splotchy red rash appeared 2in from shoulder over 3 days period, rash spread to include area from 3in below shoulder to 2in from elbow w/o itching w/raised bumps;diarrhea x 2 days 25JAN;
No additional adverse events reported; improperly stored vaccines may have been administered to patients; This spontaneous report has been received from a nurse, referring to a patient of unknown gender and age. Information about the patient's pertinent medical history, concurrent conditions, and previous drugs reactions or allergies were not provided.  On 06-JAN-2020, the patient was vaccinated with an improperly stored (product storage error), pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) (Therapy type: Digital Data Logger), lot number  S006210 and expiration date 22-DEC-2020 for prophylaxis (strength, dose, dose number, frequency, route of administration, and anatomical location, were not provided).  The vaccine was stored at a temperature above 47 degree Fahrenheit (47.1 Fahrenheit), for a timeframe of 8 to 16 minutes, with no previous temperature excursion. The call was due to a Digital Data Logger.  No additional adverse events were reported.  This case is one of several cases from the same reporter.; Sender's Comments:  US-009507513-2001USA009007:
Flare of myasthenia gravis symptoms, including shortness of breath (due to muscular weakness), difficulty swallowing, ptosis, generalized extremity fatigue. Required hospitalization and administration of IVIG over two days. Improvement of MG symptoms noted following IVIG administration.
Fatigue; Chills; Muscle aches and pains,/other pain; I experienced an allergic reaction to the first injection; The injection site was real sore, and it came into the inside part of my arm; All swollen; My arm was of two different colors; Warm to the touch; This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (I experienced an allergic reaction to the first injection), VACCINATION SITE PAIN (The injection site was real sore, and it came into the inside part of my arm), SWELLING (All swollen), SKIN DISCOLOURATION (My arm was of two different colors) and BURNING SENSATION (Warm to the touch) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, the patient experienced ALLERGY TO VACCINE (I experienced an allergic reaction to the first injection), VACCINATION SITE PAIN (The injection site was real sore, and it came into the inside part of my arm), SWELLING (All swollen), SKIN DISCOLOURATION (My arm was of two different colors) and BURNING SENSATION (Warm to the touch). On an unknown date, the patient experienced FATIGUE (Fatigue), CHILLS (Chills) and MYALGIA (Muscle aches and pains,/other pain). On 20-May-2021, ALLERGY TO VACCINE (I experienced an allergic reaction to the first injection), VACCINATION SITE PAIN (The injection site was real sore, and it came into the inside part of my arm), SWELLING (All swollen), SKIN DISCOLOURATION (My arm was of two different colors) and BURNING SENSATION (Warm to the touch) had resolved. At the time of the report, FATIGUE (Fatigue), CHILLS (Chills) and MYALGIA (Muscle aches and pains,/other pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported concomitant medication for blood pressure.
pt recv vax 22MAY95 & 28MAY95 devel over 150 vesicles, t102, ha/ & sore throat; mom told the nurse had no knowledge of an exposure to wild varicella; No further details were provided;
Chills, Fever, Achy for about 12 hours on Christmas Day, Felt like she was "hit by a truck".
flare-up of lupus condition p/vax;was 1st dx w/lupus p/87 flu vax
Within 3 hrs after receiving the vaccine my vision in what seemed to be both eyes was 80% cloudy and I was very exhausted. The following day most of the vision issued returned to normal but I had distortion and floating objects in my right eye along with bright flashes and  pressure in my right eye. After following up with our prescribed online health care service twice I was told to contact a specialists. I was able to get into the eye ER Clinic and have had 3 visits including one with a Retina specialist. I still have lost part of my peripheral vision in my right eye and continue to have follow up care.
My COVID-19 started on 12/11/2022 I wasn't feeling well. My wife tested positive few days earlier. On 12/12/2022 in the morning at around 08:00AM I tested positive for COVID-19 infection.  I had a sore throat, runny nose, and fever.  I did a telehealth with my doctor who prescribed me with Paxlovid  for 5 days. After 1 week of my medication I came down  with a head cold. I had runny nose, sneezing,  and cough. My doctor told me told wait and see how things ago and also to contact him if it gets worse.
Soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 01021A and 040A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Soreness). At the time of the report, PAIN (Soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications include thyroid medication. Treatment information not provided.
This spontaneous report as received from a nurse via company representative refers to a female patient of unknown age. It was reported that the patient received each of three doses of GARDASIL "almost a year apart" (dates of vaccinations, doses lot/batch numbers, expiration dates not reported). On an unknown date, the patient got result of a positive HPV test after receiving GARDASIL. The outcome of events was unknown. The relatedness between the events and the GARDASIL was not reported. Additional information has been requested.
pt recv vax 8OCT97 & on 24OCT97 pt devel bumps similar to chickenpox on back, thigh, & chest;the rash lasted for 24hr then disappeared;it was reported that the rash was very itchy;LMP 5MAY97;pregnancy was confirmed via sonogram 5NO97;
Flu like symptoms, weakness, paralysis, anemia, persistent weakness, severe pain, numbness and tingling in fingers and toes. Unstable BP, sugar level and worsening asthma and arthritis. Diagnosis of GBS.
On the 3rd day after receiving the injection, I experienced nausea. From then on for 8 days, I had significant nausea, diarrhea, vomiting, chills, and headache. I was practically sick in bed. A week later, I got a little better and I was able to get up & drink liquids, but I still was very weak.   Weeks later, I continued to have diarrhea, vomiting, and nausea. I had a blood study done and my white blood count went up substantially by 13,000.  On 09/12/2021, I went to the ER for dehydration and I was hospitalized for 5 days. I was discharged on 09/16/2021. I was put on a pure liquid & soft diet.   I am still very stick. I have constant daily nausea and diarrhea. I still have not returned to a normal diet and I have lost 22 pounds.
Patient notified clinic on 11/21 of the following below.   Patient notes the following: 11/16: Minutes after vaccination, patient noticed pain and tenderness at site of injection. 11/17: The following day tenderness is still present and induration noted around site of injection with itchiness present. Patient made note not to scratch area. 11/17 Afternoon: Patient reports nodule rose from site of injection area with induration. Patient noted vesicle developing; reported to be superficial and less than 1 cm in diameter. 11/18: Patient noted vesicle and covered area with a dry, non-adherent dressing. 11/18 Afternoon: Patient noted induration from site of injection to elbow. 11/19: Patient noted primary vesicle ruptured, washed area with soap and water, wiped with alcohol and placed cover dressing. 11/20: Patient noted 2-3 more small vesicle development. Patient declines using any creams or antibiotic ointments. Patient places non-adherent island dressing. 11/21 (Today): Patient noted area of induration is decreasing. Patient states symptoms are all localized to site of injection area. Patient notes is still experiencing itchiness. Patient states has been taking oral Benadryl to help with itchiness. Patient declines any fever or warmness to injection site.   11/21: Patient attached photos of injection with showed development of bullae and visual induration noted. Patient encouraged to monitor for  any warmness, increase pain, fever, chills and/or signs/symptoms of infection. Patient advised to let Occupational Medicine know and/or seek urgent care depending on level of symptoms.  Patient encouraged to keep bullae covered with non-adherent dressing.   11/28: Checked in on patient. Patient noted site is still slowly improving.
Patient returned to clinic approximately 30 minutes after vaccines given due to chest pain, watery eyes, difficulty breathing that started about 10min after vaccines administered.  Very mild redness at site of varivax.  Patient was noted to be wheezing and was given an albuterol neb, prednisone and benadryl which seemed to relieve symptoms.
Rash and itching about 8 hours after receiving vaccine.  Resolved itself within about 18 hours.  Pt states that they have had numerous flu shots without reaction before.
1 of 2 pt whoe were inadvertently given Tetramune instead of Hep B; the vax was administered SC instead of IM; pt called the office to report swelling @ the inject site; pts last Tetanus Booster was less than 10 years;
Developed severe dizzyness exacerbated with head movement.  No neurological symptoms. However, did seek medical attention at ED 10/10/21 due to near syncopal episodes. All cardiac, neurological workup negative. After discharge, follow up with PC who prescribed Meclizine. Took one dose which worsened symptoms and severe lassitude.  Discontinued medication after one dose.
12 year old received 0.2ml 5-11 Pfizer dose as a booster instead of 0.3ml 12+ Pfizer.
Runny nose; Foot pain; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Runny nose) and PAIN IN EXTREMITY (Foot pain) in a male patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced RHINORRHOEA (Runny nose) and PAIN IN EXTREMITY (Foot pain). At the time of the report, RHINORRHOEA (Runny nose) and PAIN IN EXTREMITY (Foot pain) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant product reported by reporter. No treatment medication reported by reporter.
Narrative: Patient is a 75YOF who received her first dose of the Moderna COVID-19 immunization on 2/13/21. Patient contacted the call center on 3/1/2021 stating she had developed a red, itchy rash at the immunization site (left deltoid) on ~2/26/21 and requested to be seen by her PCP. During PCP visit on 3/1/21 Patient states she had taken acetaminophen for pain at the injection site for ~2 days following her immunization, then noted the delayed rash on 2/26. Patient denied pain at the injection site during this visit and noted improvement in redness, though did complain of continued urticaria. Patient advised by PCP to utilize OTC topical diphenhydramine for itching.
Received vaccine 4/5 and a week later I started having headaches, and feeling like I was hit with a baseball in the center of my chest. I went to the doctor and the ER and nothing was found.
Patient complains of pain where vaccine administered, pain at joint and with movement. Pain is worse at nighttime. Pain progressively worse. Pain started on Friday, 10/8/2021. Patient has an appointment with MD on 10/21/2021
Information has been received from a 38 year old female medical assistant with allergies to sulfonamide, iodine contrast, and nitrofurantoin (MACRODANTIN) and a medical history of chickenpox and shingles who on 22-AUG-2006, at approximately 14:00, was splashed in the right eye when she popped the top from a syringe of a dose of Varivax (lot # 652871/0430F). She stated that she tried to flush her right eye with water. After two hours, her right eye still burned. She had a minimal amount of erythema in the right sclera. There was no edema or discharge. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been received which indicated that the event completely resolved and lasted one week to 10 days. It was note that the patient had a "right eye burn - NOS." No further information is expected.
pt recv vax 930AM came back 945AM c/o itching area around site reddened;devel hives about 5 min later mom arrived stated hx of severe allerg attacks;no breathing problems noted;taken immed to ER recv shot @ ER;
vaccine administered to patient after 21st puncture of vial; 2nd dose administered >36 days after 1st dose; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTRATION ERROR (vaccine administered to patient after 21st puncture of vial) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose administered >36 days after 1st dose) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose administered >36 days after 1st dose). On 02-Dec-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (vaccine administered to patient after 21st puncture of vial). On 07-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose administered >36 days after 1st dose) had resolved. On 02-Dec-2021, PRODUCT ADMINISTRATION ERROR (vaccine administered to patient after 21st puncture of vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.